Detalhe da pesquisa
1.
Safety and Efficacy of Bempedoic Acid to Reduce LDL Cholesterol.
N Engl J Med
; 380(11): 1022-1032, 2019 03 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-30865796
2.
Effect of Etelcalcetide vs Placebo on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism: Two Randomized Clinical Trials.
JAMA
; 317(2): 146-155, 2017 01 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28097355
3.
Bone histomorphometry before and after long-term treatment with cinacalcet in dialysis patients with secondary hyperparathyroidism.
Kidney Int
; 87(4): 846-56, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25337774
4.
Assessing the treatment effect in a randomized controlled trial with extensive non-adherence: the EVOLVE trial.
Pharm Stat
; 14(3): 242-51, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25851955
5.
The FGF21 analog pegozafermin in severe hypertriglyceridemia: a randomized phase 2 trial.
Nat Med
; 29(7): 1782-1792, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37355760
6.
Myosin Inhibition in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy.
J Am Coll Cardiol
; 80(2): 95-108, 2022 07 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35798455
7.
Combination of bempedoic acid, ezetimibe, and atorvastatin in patients with hypercholesterolemia: A randomized clinical trial.
Atherosclerosis
; 320: 122-128, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33514449
8.
Lipid lowering with bempedoic acid added to a proprotein convertase subtilisin/kexin type 9 inhibitor therapy: A randomized, controlled trial.
J Clin Lipidol
; 15(4): 593-601, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34172394
9.
Assessing the treatment effect in a randomized controlled trial with extensive non-adherence: the EVOLVE trial.
Pharm Stat
; 14(4): 368, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26096896
10.
Complementary low-density lipoprotein-cholesterol lowering and pharmacokinetics of adding bempedoic acid (ETC-1002) to high-dose atorvastatin background therapy in hypercholesterolemic patients: A randomized placebo-controlled trial.
J Clin Lipidol
; 13(4): 568-579, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31202641
11.
Efficacy and Safety of Bempedoic Acid in Patients With Hypercholesterolemia and Statin Intolerance.
J Am Heart Assoc
; 8(7): e011662, 2019 04 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30922146
12.
Author Correction: The FGF21 analog pegozafermin in severe hypertriglyceridemia: a randomized phase 2 trial.
Nat Med
; 2024 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38438737
13.
Complete Hematologic and Molecular Response in Adult Patients With Relapsed/Refractory Philadelphia Chromosome-Positive B-Precursor Acute Lymphoblastic Leukemia Following Treatment With Blinatumomab: Results From a Phase II, Single-Arm, Multicenter Study.
J Clin Oncol
; 35(16): 1795-1802, 2017 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28355115
14.
Cinacalcet treatment of primary hyperparathyroidism: biochemical and bone densitometric outcomes in a five-year study.
J Clin Endocrinol Metab
; 94(12): 4860-7, 2009 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19837909
15.
Simultaneous control of PTH and CaxP Is sustained over three years of treatment with cinacalcet HCl.
Clin J Am Soc Nephrol
; 4(9): 1465-76, 2009 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-19696213
16.
Cinacalcet reduces serum calcium concentrations in patients with intractable primary hyperparathyroidism.
J Clin Endocrinol Metab
; 94(8): 2766-72, 2009 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-19470620